by admin | Aug 21, 2024 | News
SCOTTSDALE, Ariz., Aug. 22, 2024 – Amendola, a nationally recognized, award-winning healthcare technology and life sciences public relations and marketing firm, today announced that it has been selected to implement a national public relations, content and social media program by Carta Healthcare, whose mission is to reduce the costs, save time and improve the quality of clinical data abstraction.Â
“As a six-time Amendola client, the agency is part of my magic formula for business development success through powerful storytelling, category creation, and thought leadership,” said Greg Miller, Vice President of Business Development for Carta Healthcare. “We are excited to have Amendola as an extension of our team to help promote our belief that data is the most essential ingredient for improving healthcare.” Â
Clinical data abstraction is essential for hospitals to improve patient care, meet quality standards, and reduce costs. However, manual data abstraction is inefficient, labor-intensive, and expensive, leading to poor quality data. Currently, due to labor shortages and overworked staff, these methods are not sustainable and increase healthcare delivery costs. The current manual approach is inefficient and tedious, resulting in overworked and burnt-out staff.Â
To that end, Carta has developed Atlas™, an AI-powered platform that automates data abstraction for clinical registries by efficiently extracting information from medical records. By leveraging AI, Atlas increases data availability and accuracy, enabling staff to focus on other tasks and clinicians to prioritize patient care. This is executed through a “human in the loop” approach, where expert abstractors review the quality of the AI-abstracted data. Carta’s team of abstractors work alongside current staff to ensure quality of data and seamless processes. Â
“The time and effort required to cleanse and normalize data for quality initiatives too often depletes the resources essential for delivering high-quality patient care,” said agency CEO Jodi Amendola. “We are excited to help Carta Healthcare educate the market on the importance of automating and streamlining the labor-intensive process of locating and interpreting patient data for clinical registries.”Â
About AmendolaÂ
Amendola is an award-winning, insights-driven public relations and marketing firm that integrates media relations, social media, content and lead gen programs to move healthcare, life sciences/pharma and healthcare IT decision-makers to action. The agency represents some of the industry’s best-known brands as well as groundbreaking startups that are disrupting the status quo. Nearly 90% of its client base represents multi-year clients and/or repeat client executives. Amendola’s seasoned team of PR and marketing pros understand the ongoing complexities of the healthcare ecosystem and provide strategic guidance and creative direction to drive positive ROI, boost reputation and increase market share. Making an impact since 2003, Amendola combines traditional and digital media to fuel meaningful and measurable growth. For more information about the industry’s “A-Team,” visit www.acmarketingpr.com, and follow us on Twitter and LinkedIn.Â
About Carta Healthcare Â
At Carta Healthcare, we believe high-quality data is essential to improving healthcare. Current methods to abstract data for clinical registries are labor-intensive, time-consuming, and costly. By combining artificial intelligence (AI) technology with skilled expert abstractors, Carta Healthcare helps you abstract data faster, more efficiently, at a lower cost, while delivering the highest quality data.Â
Learn more about how Carta Healthcare applies the power of AI technology, combined with expert clinical data abstractors, to harness data and insights as catalysts for healthcare transformation at www.carta.healthcare. Â
Media Contact:Â Marcia G. Rhodes, mrhodes@acmarketingpr.com, Amendola CommunicationsÂ
# # #Â
by Administrator | Jun 27, 2024 | News
SCOTTSDALE, Ariz.—June 27, 2024 – Amendola Communications today announced it has won three top Hermes Creative Awards, demonstrating the company’s solid commitment to delivering outstanding results for its healthcare and health IT clients.Â
The Hermes Creative Awards, one of the oldest and largest competitions in the world, recognized Amendola with a trio of 2024 Platinum awards for its work on behalf of clients in 2022 and 2023. The judges honored Amendola with its highest awards for the following work:Â Â
- An integrated marketing campaign on behalf of Medicomp Systems, a physician-driven provider of diagnostically connected patient data solutions. Amendola won for its well-coordinated campaign that amplified Medicomp’s message and cut through the noise in a field crowded with evolving regulations and emerging technologies, including AI. Â
- A PR campaign for KeyCare, the nation’s first Epic-based virtual care platform. Through strategic planning and creative storytelling, Amendola took KeyCare from an unknown startup to a leading player in the crowded virtual care field.Â
- A PR campaign on behalf of SteadyMD, which powers high-quality telehealth experiences for digital healthcare companies, labs, pharmacies, large employers, and other healthcare innovators. Building upon the explosion in popularity of weight loss drugs, Amendola crafted a campaign that positioned its client as an authority on how digital medicine could be used to responsibly manage demand for the medications, guide patients to weight loss, and provide appropriate care.Â
Amendola is a multi-year Hermes award winner and is marking its 20-year anniversary as a full-service PR and marketing agency focused on healthcare, health tech and life sciences with a new logo, a brand refresh, and a shiny new website—which you can check out here.   Â
“The agency consistently delivers amazing work on behalf of our clients, and it is truly gratifying to have campaigns for three separate clients singled out as among the best in the world,” said agency CEO Jodi Amendola. “It’s a testament to our team’s extensive healthcare experience, knowledge and overall dedication to delivering excellence on behalf of our clients.”
Hermes Creative Awards is sponsored by the Association of Marketing and Communication Professionals, which engages senior-level professionals to serve as competition judges who evaluate the creative industry’s best publications, branding collateral, websites, videos, and advertising, marketing, and communication programs. Its annual contest draws thousands of entries from across the globe. More information on winning entries can be found here.Â
About Amendola Â
Amendola is an award-winning, insights-driven public relations and marketing firm that integrates media relations, social media, content and lead-gen programs to move healthcare, life sciences/pharma and healthcare IT decision-makers to action. The agency represents some of the industry’s best-known brands, as well as groundbreaking startups that are disrupting the status quo. Nearly 90% of its client base represents multi-year clients and/or repeat client executives. Amendola’s seasoned team of PR and marketing pros understand the ongoing complexities of the healthcare ecosystem and provide strategic guidance and creative direction to drive positive ROI, boost reputation and increase market share. Making an impact since 2003, Amendola combines traditional and digital media to fuel meaningful and measurable growth. For more information about the industry’s “A-Team,” visit www.acmarketingpr.com, and follow us on Twitter and LinkedIn.Â
Media Contact:
Marcia G. Rhodes
Amendola Communications
mrhodes@acmarketingpr.com
by Administrator | Apr 23, 2024 | News
SCOTTSDALE, Ariz., April 23, 2024 – Amendola, a nationally recognized, award-winning healthcare technology and life sciences public relations and marketing firm, today announced that it has been selected to implement a national PR program by Peerbridge Health, developer of a hospital-grade, remote diagnostic and monitoring platform that harnesses artificial intelligence (AI) for early detection of heart failure and other conditions. Â
“Amendola comes highly recommended by healthcare technology peers, giving us confidence that its industry-specific expertise and successful track record will produce valuable results,” said Chris Darland, CEO of Peerbridge Health. “We look forward to working with Amendola to educate the industry on the life-saving potential of early detection of heart failure through AI-enabled remote monitoring technology, which we are able to offer at a significantly lower cost compared to traditional methods.” Â
More than 6 million Americans live with heart failure, and each year around 1 million new cases are diagnosed in adults 55 years of age and over. Heart failure is the second-leading cause of hospitalization in the U.S. and the leading cause of hospitalization among adults 65 and older.Â
To reduce the impact of heart failure, Peerbridge Health has developed the Peerbridge Cor™, an AI-enabled, 3-lead, 2-channel wireless ambulatory ECG device. A recent feasibility trial showed the device had a nearly 96% accuracy rate in identifying heart failure in patients utilizing ECG as the only input.Â
“Heart failure is a serious condition that is often only diagnosed after a visit to the emergency room,” said agency CEO Jodi Amendola. “We are pleased to partner with Peerbridge Health in its efforts to extend access to care, improve outcomes for cardiac patients, and reduce the financial burden of this disease.”  Â
About AmendolaÂ
Amendola is an award-winning, insights-driven public relations and marketing firm that integrates media relations, social media, content and lead gen programs to move healthcare, life sciences/pharma and healthcare IT decision-makers to action. The agency represents some of the industry’s best-known brands as well as groundbreaking startups that are disrupting the status quo. Nearly 90% of its client base represents multi-year clients and/or repeat client executives. Amendola’s seasoned team of PR and marketing pros understand the ongoing complexities of the healthcare ecosystem and provide strategic guidance and creative direction to drive positive ROI, boost reputation and increase market share. Making an impact since 2003, Amendola combines traditional and digital media to fuel meaningful and measurable growth. For more information about the industry’s “A-Team,” visit www.acmarketingpr.com, and follow us on Twitter and LinkedIn.Â
About Peerbridge HealthÂ
Peerbridge Health is revolutionizing cardiac care as the first company to bring the quality and accuracy of hospital-grade cardiac diagnostics to the home. The company’s AI-enabled device, Peerbridge Cor™, includes a three-lead, patented AECG wearable device that features a design based on the Einthoven Triangle. The Peerbridge platform leverages ECG to diagnose and monitor the most important elements of cardiac care at a lower cost than ever before. Data captured provides actionable insights that promote early invention, reduce hospital visits and saves lives. For more, go to peerbridgehealth.com or visit our LinkedIn page.Â
Media Contact:Â
Marcia G. Rhodes, mrhodes@acmarketingpr.comÂ
# # #Â
by Brandon Glenn | Apr 17, 2024 | Blog
As a dutiful student and practitioner of public relations, corporate communications, and journalism, I have become intimately familiar with AP style – like it or not.
For example, I know that “Wi-Fi” is for some reason capitalized at all times and hyphenated regardless of where it’s used in a sentence.
I know that the word “unique” should never be used with a qualifier. Unique means “one-of-a-kind,” so what is the difference between something that is “very” or “rather” one-of-a-kind vs. something that is simply one-of-a-kind?
I know that Oxford commas are an affront to humanity and must be relegated to the ash heap of history.
Unfortunately, I’ve spent enough time learning, studying, and practicing these rules to wish for several years of my life back. Yet there is one AP style rule I keep coming back to mentally and have never been able to get out of my head since I learned it many years ago.
Who vs. that: Who is it that actually spent time thinking about this?
The best rule in the AP style pertains to the answer to a question that few people have ever dared to ask, and even fewer could bear the weight of fully contemplating: When we are referring to animals, is the appropriate relative pronoun “who” or “that”?
In other words, which is the right choice: “The dog who chased after the car” or “the dog that chased after the car”? “The rhinoceros who is bathing in the river” or “the rhinoceros that is bathing in the river”? (Side note: If I’m interpreting AP style correctly, the question marks in the previous paragraphs should be outside the quotation marks.)
Leave it to those visionary and imaginative AP style editors to come up with an answer that sheds much-needed clarity on an issue that most of us would find too trivial to even ponder: “It depends.”
Yes, it’s true. When confronted with a monumental, mind-blowing question that would affect the course of countless lives and have far-reaching implications for the future of humanity over decades to come, the AP style editors opted to hedge by choosing an answer with a little from column A, and a little from column B.
So, here’s the rule: Animals with names should be referred to as “who,” while animals without names should be referred to as “that” or “which.”
I’m not making this up. People were actually (presumably) paid real, legitimate money to sit around discussing this pressing and contentious issue, and this is what they thought was the best outcome. Alas, how we should refer to animals that/who may or may not have names, such as a stray cat that/who once had a name and guardian but now lives anonymously on the streets, remains frustratingly unclear.
I can’t help but fantasize about being a fly on the wall for the discussions that led to the creation of this rule. I can only hope it was an intense, hours-long discussion in the glass-walled conference room of a sleek urban high rise, with advocates of both sides of the debate having prepared long and detailed slide decks that present their sides of the case in agonizing detail.
I imagine that passions became so heated and rivalries grew so fierce between the “who” side and the “that” side that a couple of the editors nearly came to violent blows as they had to be separated by shocked, fearful colleagues who had underestimated the near-religious fervor such a debate would inspire.
I have a difficult time believing that AP style has ever given us a more unnecessary and largely pointless distinction than the “who” vs. “that” named-animal-rule controversy, but I hold out hope that there are even more obscure, dumber rules to discover as I continue my lifelong AP style learning pursuit.
by Administrator | Apr 4, 2024 | News
SCOTTSDALE, Ariz., April 4 2024 – Amendola, a nationally recognized, award-winning healthcare technology and life sciences public relations and marketing firm, announced that it has been selected by Lindus Health, an “anti-CRO” running radically faster, more reliable clinical trials for life science pioneers, to implement a national PR Program.
Lindus Heath chose Amendola to help the company drive awareness and interest in its unified technology, site services, and CRO services package that enables sponsors to run faster, higher-quality studies for regulatory approvals and payor access.
Amendola is implementing a comprehensive PR plan to demonstrate Lindus Health’s industry-leading technology and services, accomplishments, customer wins, and industry partnerships.
“New drugs and healthcare treatments must undergo clinical trials to show they are safe and effective, but it has gotten exponentially more time consuming and expensive for sponsors to run these clinical trials,” said Meri Beckwith, Co-Founder of Lindus Health. “We are thrilled to work with Amendola to demonstrate to the market how Lindus Health’s new model offers more rapid, high-quality clinical trials together with transparent pricing.”
Lindus Health has created a new “all-in-one” model for running end-to-end clinical trials, which includes everything that a traditional research organization does to operate a study – protocol writing, trial design, patient recruitment, and clinical operations delivery – but without the traditional headaches, delays, and extra costs. The company is passionate about using the highest-quality scientific methods available and homegrown cutting-edge technology, including AI, to conduct radically faster, more reliable clinical trials.
“Leaders from across the life sciences industry are tired of the status quo of CROs substantially overrunning on timelines, constantly issuing change orders based on hourly billing that cause budget overruns, and providing poor customer service,” said agency CEO, Jodi Amendola. “Lindus Health is poised to transform how clinical trials are executed and we look forward to raising awareness across the industry.”
About Lindus Health
Lindus Health is an anti-CRO running radically faster and more reliable trials for life science pioneers – bringing ground-breaking treatments to patients more quickly. Lindus Health does this thanks to a commercial model that aligns incentives (fixed-priced quotes per study, with milestone-based payments), marrying a world-class clinical operations team with its unique software platform, and access to 30 million Electronic Health Records. Clinical trials are the biggest bottleneck to advances in healthcare and by removing this constraint they aim to improve health for everyone. They handle the end-to-end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management.
About Amendola
Amendola is an award-winning, insights-driven public relations and marketing firm that integrates media relations, social media, content and lead gen programs to move healthcare, life sciences/pharma and healthcare IT decision-makers to action. The agency represents some of the industry’s best-known brands as well as groundbreaking startups that are disrupting the status quo. Nearly 90% of its client base represents multi-year clients and/or repeat client executives. Amendola’s seasoned team of PR and marketing pros understand the ongoing complexities of the healthcare ecosystem and provide strategic guidance and creative direction to drive positive ROI, boost reputation and increase market share. Making an impact since 2003, Amendola combines traditional and digital media to fuel meaningful and measurable growth. For more information about the industry’s “A-Team,” visit www.acmarketingpr.com, and follow us on Twitter and LinkedIn.
Media Contact: Marcia G. Rhodes, mrhodes@acmarketingpr.com
# # #
